Sign in

CIK 0001650648

  • Non-accelerated filer
  • Smaller reporting company

4D Molecular Therapeutics, Inc.

Sign in to watch
Ticker
FDMT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473506994
Phone
+1 510-505-2680
Business address
5858 HORTON STREET #455, EMERYVILLE, CA, 94608
Former names
4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,616,428
in 5 filings, $1.6M under 10b5-1 plans

Net −$1,616,428. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-20 Gupta Ashoo VP, Finance and Controller Exercise or conversion +865 47,224
2026-03-20 Gupta Ashoo VP, Finance and Controller Sale −310 $8.61 $3K 46,914
2026-03-20 Gupta Ashoo VP, Finance and Controller Exercise or conversion +221 47,135
2026-03-20 Gupta Ashoo VP, Finance and Controller Sale −80 $8.61 $689 47,055
2026-03-20 Gupta Ashoo VP, Finance and Controller Exercise or conversion · Restricted Stock Units −865 12,119
2026-03-20 Gupta Ashoo VP, Finance and Controller Exercise or conversion · Restricted Stock Units −221 3,087
2025-12-20 Gupta Ashoo VP, Finance and Controller Exercise or conversion +866 46,528
2025-12-20 Gupta Ashoo VP, Finance and Controller Sale −310 $8.68 $3K 46,218
2025-12-20 Gupta Ashoo VP, Finance and Controller Exercise or conversion +220 46,438
2025-12-20 Gupta Ashoo VP, Finance and Controller Sale −79 $8.68 $686 46,359
2025-12-20 Gupta Ashoo VP, Finance and Controller Exercise or conversion · Restricted Stock Units −866 12,984
2025-12-20 Gupta Ashoo VP, Finance and Controller Exercise or conversion · Restricted Stock Units −220 3,308

Page 1 of 1 · 12 trades